Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pegvisomant 10mg inj vials
0605010Z0AAAAAA
|
Pegvisomant | Pegvisomant | Endocrine System | No data available |
|
Pegvisomant 15mg inj vials
0605010Z0AAABAB
|
Pegvisomant | Pegvisomant | Endocrine System | No data available |
|
Pegvisomant 20mg inj vials
0605010Z0AAACAC
|
Pegvisomant | Pegvisomant | Endocrine System | No data available |
|
Pegvisomant 25mg inj vials
0605010Z0AAADAD
|
Pegvisomant | Pegvisomant | Endocrine System | No data available |
|
Pegvisomant 30mg inj vials
0605010Z0AAAEAE
|
Pegvisomant | Pegvisomant | Endocrine System | No data available |
|
Somavert 10mg inj vials
0605010Z0BBAAAA
|
Somavert | Pegvisomant | Endocrine System | No data available |
|
Somavert 15mg inj vials
0605010Z0BBABAB
|
Somavert | Pegvisomant | Endocrine System | No data available |
|
Somavert 20mg inj vials
0605010Z0BBACAC
|
Somavert | Pegvisomant | Endocrine System | No data available |
|
Somavert 25mg inj vials
0605010Z0BBADAD
|
Somavert | Pegvisomant | Endocrine System | No data available |
|
Somavert 30mg inj vials
0605010Z0BBAEAE
|
Somavert | Pegvisomant | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.